Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6135683 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1CYP3A4LMNATDP1 | |
| SCHEMBL31538353 | 0.79 | ALOX15 (0.53) | ALOX15ALDH1A1CYP3A4LMNATDP1 | |
| SCHEMBL17079529 | 0.79 | ALOX15 (0.56) | ALOX15ALDH1A1CYP3A4LMNATDP1 | |
| SCHEMBL1614306 | 0.77 | ALOX15 (0.58) | ALOX15ALDH1A1LMNACHRNB2CHRNA4 | |
| SCHEMBL1613577 | 0.77 | ALOX15 (0.54) | ALOX15ALDH1A1LMNACHRNB2CHRNA4 | |
| SCHEMBL1613574 | 0.77 | ALOX15 (0.54) | ALOX15ALDH1A1LMNACHRNB2CHRNA4 | |
| SCHEMBL7552905 | 0.75 | ALOX15 (0.70) | ALOX15ALDH1A1LMNACHRNB2CHRNA4 | |
| SCHEMBL7782877 | 0.74 | ALDH1A1 (0.41) | ALOX15ALDH1A1CYP3A4LMNATDP1 | |
| SCHEMBL7782876 | 0.74 | ALDH1A1 (0.41) | ALOX15ALDH1A1CYP3A4LMNATDP1 | |
| SCHEMBL31538381 | 0.74 | ALOX15 (0.51) | ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12344569-B2 | Process for making a conjugated diene from an allyl alcohol | GIVAUDAN SA (CH) | 2025-07-01 | — | — | US | claimed |
| EP-4168383-B1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | GIVAUDAN SA (CH) | 2024-07-31 | — | — | EP | claimed |
| US-20230322645-A1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | GIVAUDAN SA (CH) | 2023-10-12 | — | — | US | claimed |
| EP-1373548-B1 | CHEMO-ENZYMATIC SYNTHESIS OF OPTICALLY ENRICHED ROSE-OXIDES | COUNCIL SCIENT IND RES (IN) | 2005-07-13 | — | — | EP | disclosed |
| US-6692944-B2 | Chemo-enzymatic synthesis of optically enriched rose-oxides | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2004-02-17 | — | — | US | disclosed |
| EP-1373548-A1 | CHEMO-ENZYMATIC SYNTHESIS OF OPTICALLY ENRICHED ROSE-OXIDES | Council of Scientific and Industrial Research (IN) | 2004-01-02 | — | — | EP | disclosed |
| WO-2003087387-A1 | CHEMO-ENZYMATIC SYNTHESIS OF OPTICALLY ENRICHED ROSE-OXIDES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-23 | — | — | WO | disclosed |
| US-20030186395-A1 | Chemo-enzymatic synthesis of optically enriched rose-oxides | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2003-10-02 | — | — | US | disclosed |
| EP-0761628-B1 | Method for producing 3,7-dimethyl-5,7-octadiene-1-ol or rose oxide | TAKASAGO PERFUMERY CO LTD (JP) | 2001-11-14 | — | — | EP | disclosed |
| US-5672783-A | Method for producing 3,7-dimethyl-5,7-octadiene-1-ol or rose oxide | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1997-09-30 | — | — | US | disclosed |
| EP-0761628-A1 | Method for producing 3,7-dimethyl-5,7-octadiene-1-ol or rose oxide | Takasago International Corporation (JP) | 1997-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12344569-B2 | Process for making a conjugated diene from an allyl alcohol | ADH1C, ADH1A, ADH5 | ALOX15 147/4885ALDH1A1 17/4885CYP3A4 239/4885 |
| US-20230322645-A1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | ADH1C, ADH1A, ADH5 | ALOX15 147/4885ALDH1A1 17/4885CYP3A4 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.